We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · July 16, 2020

DOACs vs Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation

Stroke: A Journal of Cerebral Circulation

 

Additional Info

Stroke: A Journal of Cerebral Circulation
Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation
Stroke 2020 Jul 09;[EPub Ahead of Print], JB Wetmore, NS Roetker, H Yan, JL Reyes, CA Herzog

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading